Clinical trial
Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer
NCT00072787 · Taiho Oncology, Inc., Industry · Completed
Key facts
| NCT number | NCT00072787 |
|---|---|
| Title | Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer |
| Official title | A Phase I/II, Open-Label, Nonrandomized, Dose-Finding Safety, Tolerance, Pharmacokinetic, and Efficacy Study of Orally Administered S-1 in Combination With Cisplatin in Patients With Advanced Gastric Cancer |
| Lead sponsor | Taiho Oncology, Inc., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug |
| Interventions | S-1, cisplatin |
| Enrollment | 41 |
| Start date | Oct 1, 2003 |
| Primary completion | Mar 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Nov 13, 2003 |
| Last update posted | Sep 3, 2024 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: